Incidence, clearance and predictors of human papillomavirus infection in women

CMAJ. Canadian Medical Association Journal

Volumn 168, Issue 4, 2003, Pages 421-425

  Sellors, John W ^a,b,c   Karwalajtys, Tina L ^a,b   Kaczorowski, Janusz ^b   Mahony, James B ^b   Lytwyn, Alice ^e   Chong, Sylvia ^a   Sparrow, Joanna ^a   Lorincz, Attila ^d  

^a ST JOSEPH S HOSPITAL   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

^c PATH   (United States)

^d Digene Corporation   (United States)

^e Digene Corporation ^*

Author keywords

[No Author keywords available]

Indexed keywords

ORAL CONTRACEPTIVE AGENT;

ADOLESCENT; ADULT; ARTICLE; CARCINOGENICITY; CONTROLLED STUDY; FEMALE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MARRIAGE; ONCOVIRINAE; PERSISTENT INFECTION; PREDICTION; PREVALENCE; RISK FACTOR; SEXUALITY; SMOKING; VIRUS INFECTION; WART VIRUS;

EID: 0037452801     PISSN: 08203946     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Koutsky LA, Holmes KK, Critchlow CW, Stevens CE, Paavonen J, Beckmann AM, et al. A cohort study of the risk of intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection. N Engl J Med 1992;327:1272-8.
2. Ho GYF, Bierman R, Beardsley L, Chang CJ, Burk RD. Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med 1998;338:423-8.
3. Schlecht NF, Kulaga S, Robitaille J, Ferreira S, Santos M, Miyamura RA, et al. Persistent human papillomavirus infection as a predictor of cervical intraepithelial neoplasia. JAMA 2001;286:3106-14.
4. Walboomers JMM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999;189:1-3.
5. Sellors JW, Mahony JB, Kaczorowski J, Lytwyn A, Bangura H, Chong S, et al. Human papillomavirus infection in Ontario women: prevalence and predictors. CMAJ 2000;163(5):503-8.
6. Evander M, Edlund K, Gustafsson A, Jonsson M, Karlsson R, Rylander E, et al. Human papillomavirus infection is transient in young women: a population-based cohort study. J Inject Dis 1995;171:1026-30.
7. Moscicki AB, Nills N, Shiboski S, Powell K, Jay N, Hanson E, et al. Risks for incident human papillomavirus infection and low-grade squamous intraepithelial lesion development in young females. JAMA 2001;285(23):2995-3002.
8. Hildesheim A, Schiffman MH, Gravitt PE, Glass AG, Greer CE, Zhang T, et al. Persistence of type-specific human papillomavirus infection among cytologically normal women. J Infect Dis 1994;169:235-40.
9. Wheeler CM, Greer CE, Becker TM, Hunt WC, Anderson SM, Manos MM. Short-term fluctuations in the detection of cervical human papillomavirus DNA. Obstet Gynecol 1996;88(2):261-8.
10. Ahdieh L, Klein RS, Burk R, Cu-Uvin S, Schuman P, Duerr A, et al. Prevalence, incidence, and type-specific persistence of human papillomavirus in human immunodeficiency virus (HIV)-positive and HIV-negative women. J Infect Dis 2001;184:682-90.
11. Hankins C, Coutlee F, Lapointe N, Simard P, Tran T, Samson J, et al. Prevalence of risk factors associated with human papillomavirus infection in women living with HIV. Canadian Women's HIV Study Group. CMAJ 1999;160(2):185-91.
12. Lorincz A. Molecular methods for the detection of human papillomavirus infection. Obstet Gynecol Clin North Am 1996;23:707-30.
13. Munoz N, Kato I, Bosch FX, Eluf-Neto J, de Sanjose S, Ascunce N, et al. Risk factors for HPV DNA detection in middle-aged women. Sex Transm Dis 1996;23(6):504-10.
14. Schiffman M, Herrero R, Hildesheim A, Sherman ME, Bratti M, Wacholder S, et al. HPV DNA testing in cervical cancer screening; results from women in a high-risk province of Costa Rica. JAMA 2000;238:87-93.
15. Sherman ME, Schiffman M, Cox JT, ALTS group. Effects of age and human papilloma viral load on colposcopy triage: data from the randomized Atypical Squamous Cells of Undetermined Significance/Low Grade Squamous Intraepithelial Lesion Triage Study (ALTS). J Natl Cancer Inst 2002;94(2):102-7.